Sympathomimetic effects of paraxanthine and caffeine in humans.
about
Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's diseaseElevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and CaffeineCoffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study.K+ transport in resting rat hind-limb skeletal muscle in response to paraxanthine, a caffeine metabolite.Paraxanthine, a caffeine metabolite, dose dependently increases [Ca(2+)](i) in skeletal muscle.Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic miceCaffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediatorsDose-dependent pharmacokinetics and psychomotor effects of caffeine in humans.Clinical and physiological correlates of caffeine and caffeine metabolites in primary insomniaNrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine.PharmGKB summary: caffeine pathway.Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI-MS/MS and clinical application.Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humansIntegrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease.Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission.Emerging treatments for narcolepsy and its related disorders.Nutraceutical supplements for weight loss: a systematic review.Caffeine in tea Camellia sinensis--content, absorption, benefits and risks of consumption.Physiological effects of caffeine, epigallocatechin-3-gallate, and exercise in overweight and obese women.Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.Effect of a divided caffeine dose on endurance cycling performance, postexercise urinary caffeine concentration, and plasma paraxanthine.Foetal response to maternal coffee intake: role of habitual versus non-habitual caffeine consumption.Interaction between maternal caffeine intake during pregnancy and CYP1A2 C164A polymorphism affects infant birth size in the Hokkaido study.Hepatoprotective Effect of Low Doses of Caffeine on CCl4-Induced Liver Damage in Rats.Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease.Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis.Effect of a thermogenic beverage on 24-hour energy metabolism in humans.Integrated metabolomics and metallomics analyses in acute coronary syndrome patients.A fatal case involving a caffeine-containing fat burner
P2860
Q24604052-BA26A1E8-DB89-4B3B-8A2A-B25CCF5FC429Q24608522-DFC8F95A-9097-4890-9E62-A6909AD1CE71Q33741759-1B8DD5C7-DA67-44D5-B5D1-5E72CC86CE70Q33883279-62253442-E436-4383-95C5-4F002EBCB100Q33926127-701CE4F0-263A-4E52-881E-08846A185051Q33950203-60412596-7CCC-45FA-845D-539868B945D9Q34279284-5DB9C4AE-594D-4A93-87D5-ABBD0517F110Q34743637-58820A55-A0D2-4F32-A700-83DCA274B3B9Q34797981-2D1D7426-1E6E-4F88-AC2A-CA61682945D1Q35079069-656E9ECB-3FF8-4FF5-8203-2A7920172003Q36054907-77AFB7B9-6463-4FFF-8AD2-50BC67091D26Q36198458-496EE56C-9C32-4B3B-B636-7D42050FD854Q36581904-43CE0E9A-B38B-4D05-8F7C-5C639C77A3CEQ36638223-7BEA56BF-37D3-40E8-BAA5-9BA08E3C7267Q36924618-F24F7F2F-A1BB-4030-8871-3B280DA46A38Q37694570-49155295-0802-4657-BFB5-FB41D728A3CFQ37938801-CF65067E-40EB-475C-AE06-EF20A7116EA2Q38187564-ED47CA23-8DAF-4F1A-A8EB-69C6180BCB9AQ38480473-1C54D1C6-B8B4-4ACF-A1FC-7E53C2F566ABQ39157059-DEDD620C-5227-4492-AD9D-E1D5CE2108E2Q44249708-205D4774-9D79-490B-8EAB-F8CD3AD68B21Q45977825-60E06EFD-805E-46DD-823A-47B2D7357AF1Q47224986-587F33A4-DE8D-4E39-8459-318C6728BA31Q47829842-DACA90C8-95C1-404F-9FD9-ECD00737332AQ50125651-33995E91-90D4-4D82-A52B-C1D641B16546Q50523966-B2F7CBF2-753B-477D-AD1E-8A28589F9A5DQ50697289-EC870CA2-BA37-46FE-B644-B94571E65B62Q53285481-669115D2-2C24-4A14-B0F2-1B555C4382DBQ56656605-E68AA8CD-231F-4221-9CB1-A1A6B4EABAC1
P2860
Sympathomimetic effects of paraxanthine and caffeine in humans.
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Sympathomimetic effects of paraxanthine and caffeine in humans.
@ast
Sympathomimetic effects of paraxanthine and caffeine in humans.
@en
type
label
Sympathomimetic effects of paraxanthine and caffeine in humans.
@ast
Sympathomimetic effects of paraxanthine and caffeine in humans.
@en
prefLabel
Sympathomimetic effects of paraxanthine and caffeine in humans.
@ast
Sympathomimetic effects of paraxanthine and caffeine in humans.
@en
P2093
P1476
Sympathomimetic effects of paraxanthine and caffeine in humans.
@en
P2093
P304
P356
10.1016/0009-9236(95)90025-X
P407
P577
1995-12-01T00:00:00Z